Search results for "Prognosis."

showing 10 items of 2044 documents

Inflammation and Aortic Stiffness: An Individual Participant Data Meta‐Analysis in Patients With Inflammatory Bowel Disease

2017

Background The recent finding that aortic pulse wave velocity ( aPWV ) is increased in patients with inflammatory bowel disease may explain why the cardiovascular risk is increased despite the low prevalence of traditional cardiovascular risk factors. We aimed to test whether inflammation is associated with aortic stiffening in this setting after adjustment for major confounders and to perform subgroup analyses. Methods and Results A systematic literature search for aPWV in inflammatory bowel disease was performed using PubMed, Scopus, Web of Science, and Google Scholar databases (last accessed May 7, 2017). Inclusion criterion was peer‐reviewed publications on clinical studies reporting o…

medicine.medical_specialtySettore MED/09 - Medicina Internapulse wave velocitycardiovascular complicationsBlood SedimentationPulse Wave Analysis030204 cardiovascular system & hematologyStandard scoreInflammatory bowel diseaseLeukocyte Count03 medical and health sciencesVascular Stiffness0302 clinical medicineCrohn DiseaseRisk FactorsInternal medicinemedicineHumansArterial stiffness; Cardiovascular complications; Crohn's disease; Inflammation; Pulse wave velocity; Ulcerative colitis; Cardiology and Cardiovascular Medicine030212 general & internal medicineulcerative colitisInflammationSystematic Review and Meta‐AnalysisCrohn's diseasemedicine.diagnostic_testbusiness.industryMeta Analysisinflammation aortic stiffnessPrognosismedicine.diseaseUlcerative colitisConfidence intervalCrohn's diseaseC-Reactive Proteinarterial stiffnessCardiovascular DiseasesMeta-analysisErythrocyte sedimentation rateMultivariate AnalysisHypertensionLinear ModelsPhysical therapyArterial stiffnessColitis UlcerativeInflammation MediatorsCardiology and Cardiovascular MedicinebusinessBiomarkersJournal of the American Heart Association
researchProduct

Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study

2021

The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension conceived and designed an ad hoc study aimed at searching for prognostic cut-off values of serum uric acid (SUA) in predicting combined (fatal and non-fatal) cerebrovascular (CBV) events in the whole database. The URic acid Right for heArt Health study is a nationwide, multicenter, observational cohort study involving data on subjects aged 18-95 years recruited on a regional community basis from all the territory of Italy under the patronage of the Italian Society of Hypertension with a mean follow-up period of 120.7 ± 61.8 months. A total of 14,588 subjects were included in the analysis. A prognos…

medicine.medical_specialtySettore MED/09 - Medicina Internauric acid cardiovascular riskserum uric acid; stroke; hypertension; cardiovascular prevention; cardiovascular diseasechemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansStrokeuric acid hypertensionbusiness.industryConfoundingPrognosismedicine.diseaseConfidence intervalUric AcidStrokechemistryHypertensionUric acidbusinessBody mass indexCohort studyKidney disease
researchProduct

Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the L…

2020

Background: Melanoma is the most lethal skin cancer with a mortality rate of 262 cases per 100.000 cases. The sentinel lymph node (SLN) is the first lymph node draining the tumor. SLN biopsy is a widely accepted procedure in the clinical setting since it provides important prognostic information, which helps patient management, and avoids the side effects of complete lymph node dissection. The rationale of identifying and removing the SLN relies on the low probability of subsequent metastatic nodes in case of a negative histological exam performed in the SLN. Discussion: Recently, new analytical approaches, based on the evaluation of scintigraphic images are also exploring the possibility …

medicine.medical_specialtySingle Photon Emission Computed Tomography Computed TomographySkin NeoplasmsSentinel lymph nodeSingle-photon emission computed tomographySentinel lymph node biopsyhybrid imagingBiopsymedicineHumansRadiology Nuclear Medicine and imagingsentinel lymph node biopsyMelanomaLymph nodePharmacology99mTc-Tilmanoceptmedicine.diagnostic_testbusiness.industryMelanomaSPECT/CTSentinel nodePrognosismedicine.disease99mTc-colloids; 99mTc-Tilmanocept; Hybrid imaging; Melanoma; Sentinel lymph node biopsy; SPECT/CT; Humans; Lymphoscintigraphy; Melanoma; Prognosis; Radiopharmaceuticals; Sentinel Lymph Node; Single Photon Emission Computed Tomography Computed Tomography; Skin NeoplasmsDissectionHybrid imagingmedicine.anatomical_structure99mTc-colloidsRadiologyRadiopharmaceuticalsSentinel Lymph NodeSkin cancerbusinessLymphoscintigraphyCurrent Radiopharmaceuticals
researchProduct

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – update 2018

2019

Merkel cell carcinoma (MCC, ICD-O M8247 / 3) is a rare malignant primary skin tumor with epithelial and neuroendocrine differentiation. The neoplastic cells share many morphological, immunohistochemical and ultrastructural characteristics with Merkel cells of the skin. The diagnosis of MCC is rarely made on clinical grounds. Histological and immunohistochemical studies are usually required to confirm the clinical suspicion. Given the frequent occurrence of occult lymph node metastasis, sentinel lymph node biopsy should be performed once distant metastasis has been ruled out by cross-sectional imaging. Primary tumors without evidence of organ metastases are treated with complete surgical exc…

medicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentSentinel lymph nodeMedizinAntineoplastic AgentsDermatologyNeuroendocrine differentiation030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineBiopsyCarcinomaHumansMedicineNeoadjuvant therapyAgedNeoplasm Stagingmedicine.diagnostic_testbusiness.industryMerkel cell carcinomaPrognosismedicine.diseaseNeoadjuvant TherapyCarcinoma Merkel CellRadiation therapymedicine.anatomical_structureLymphatic MetastasisImmunotherapyRadiologyNeoplasm Recurrence LocalCognition DisordersbusinessMerkel cell
researchProduct

New advances in radiomics of gastrointestinal stromal tumors

2020

Gastrointestinal stromal tumors (GISTs) are uncommon neoplasms of the gastrointestinal tract with peculiar clinical, genetic, and imaging characteristics. Preoperative knowledge of risk stratification and mutational status is crucial to guide the appropriate patients' treatment. Predicting the clinical behavior and biological aggressiveness of GISTs based on conventional computed tomography (CT) and magnetic resonance imaging (MRI) evaluation is challenging, unless the lesions have already metastasized at the time of diagnosis. Radiomics is emerging as a promising tool for the quantification of lesion heterogeneity on radiological images, extracting additional data that cannot be assessed b…

medicine.medical_specialtyStromal cellGastrointestinal Stromal TumorsComputed tomographyTexture analysis.Clinical applications03 medical and health sciences0302 clinical medicineMagnetic resonance imagingRadiomicsmedicineMutational statusHumansComputed tomographyGastrointestinal NeoplasmsRadiomicsmedicine.diagnostic_testbusiness.industryGastroenterologyMagnetic resonance imagingMinireviewsGeneral MedicinePrognosisClinical applicationClinical PracticeTexture analysis030220 oncology & carcinogenesisRisk stratification030211 gastroenterology & hepatologyRadiologyDifferential diagnosisGastrointestinal stromal tumorRadiomicbusinessTomography X-Ray Computed
researchProduct

The challenge of the volume status assessment in heart failure.

2009

medicine.medical_specialtySystoleBlood volumeDoppler echocardiographyVentricular Dysfunction LeftInternal medicinemedicineIntravascular volume statusVentricular PressureHumansSystoleHeart FailureBlood Volumemedicine.diagnostic_testbusiness.industryDisease progressionmedicine.diseasePrognosisEchocardiography DopplerHeart failureCardiologyVentricular pressureheart failure volume status assessmentDisease ProgressionCardiology and Cardiovascular MedicinebusinessAmerican heart journal
researchProduct

Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis

2020

BACKGROUND AND PURPOSE To test the hypothesis that total tau (tTau), tau phosphorylated at threonine 181 (pTau) and pTau/tTau ratio in the cerebrospinal fluid (CSF) are diagnostic and prognostic biomarkers of amyotrophic lateral sclerosis (ALS), we performed a retrospective observational study in a large cohort of ALS patients and controls. METHODS We enrolled 196 ALS patients and 91 controls, who included patients with ALS-mimicking diseases and those with non-neurodegenerative diseases. All patients underwent lumbar puncture for CSF analysis at the time of the diagnostic evaluation or to first referral. We measured tTau and pTau levels in the CSF by chemiluminescence enzyme immunoassay. R…

medicine.medical_specialtyTau proteintau ProteinsGastroenterology03 medical and health sciences0302 clinical medicineCerebrospinal fluidInternal medicineHumansMedicine030212 general & internal medicineAmyotrophic lateral sclerosisALS biomarker CSF Taubiologybusiness.industryAmyotrophic Lateral SclerosisArea under the curveRetrospective cohort studyPrognosismedicine.diseaseConfidence intervalROC CurveNeurologybiology.proteinBiomarker (medicine)Neurology (clinical)Age of onsetbusinessBiomarkers030217 neurology & neurosurgeryEuropean Journal of Neurology
researchProduct

Clinical characteristics and outcomes of thymoma-associated myasthenia gravis

2021

[Background and purpose] Prognosis of myasthenia gravis (MG) in patients with thymoma is not well established. Moreover, it is not clear whether thymoma recurrence or unresectable lesions entail a worse prognosis of MG.

medicine.medical_specialtyThymomaThymomaEnfermedad del sistema nerviosoMiastenia gravischemical and pharmacologic phenomenaGastroenterology03 medical and health sciences0302 clinical medicineDisease severityRecurrenceInternal medicinehemic and lymphatic diseasesMyasthenia GravismedicineHumansIn patient030212 general & internal medicineneoplasmsNeurologíaMyasthenia gravisRetrospective Studiesbusiness.industryHazard ratioOdds ratioThymus Neoplasmsthymomamedicine.diseaseThymectomyPrognosisConfidence intervalMyasthenia gravisThymomEfectos fisiológicossurgical procedures operativeNeurologyMulticenter studySignos y síntomasNeurology (clinical)Neoplasm Recurrence LocalbusinessTimoma030217 neurology & neurosurgery
researchProduct

Predictors of Progression in Hypertensive Renal Disease in Children

2004

In hypertensive renal disease in children, several risk factors influence the development and the rate of progression of renal damage, including blood pressure levels, proteinuria, lipid disorders, and genetic differences. The impact of blood pressure on renal structures, the most important of the factors, depends not only on blood pressure levels, but also on the persistence of the blood pressure levels over time, mainly during the hours when the patient is resting or sleeping. Abnormal circadian variability is frequently observed in patients with renal damage, and nocturnal blood pressure reduction should be a major therapeutic objective to protect against a decline in renal function. Pro…

medicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismRenal functionDiseaseurologic and male genital diseasesRisk FactorsInternal medicineInternal MedicineHumansMedicineIn patientCircadian rhythmChildReview PaperProteinuriabusiness.industryRenal damageAge FactorsPrognosisNocturnal blood pressureProteinuriaBlood pressureEndocrinologyHypertensionDisease ProgressionCardiologyKidney Diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessThe Journal of Clinical Hypertension
researchProduct

Home treatment of pulmonary embolism: are all the questions answered now after the HOME-PE trial?

2020

medicine.medical_specialtyTime FactorsPhysiologyClinical Decision-MakingRisk AssessmentSeverity of Illness IndexDecision Support TechniquesPredictive Value of TestsRisk FactorsPhysiology (medical)medicineHumansIntensive care medicineLungbusiness.industryLength of StayPrognosismedicine.diseaseHome Care ServicesThrombosisPatient DischargePulmonary embolismmedicine.anatomical_structureHome treatmentPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessCardiovascular Research
researchProduct